4 July 2018 - Deborah Wilkes
Archived
Bristol-Myers Squibb is considering a range of strategic options, including divestment, for its French consumer healthcare business UPSA.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.